HALK Cafe - II

[666]

Su sizin sey vakalari ne durumdadir Drexty? 3 kisi pozitif cikmis demistin.

[Drexty]

Su sizin sey vakalari ne durumdadir Drexty? 3 kisi pozitif cikmis demistin.

Toplam 5 personelde çıktı. Erken davrandık izolasyon tedavi derken çok şükür zaiyat yok şu ana kadar

[bahriyeli]

Prof. Dr. Ercüment Ovalı 23 Nisan'ı beklemeyip ilacı duyurdu: Çok etkili, acilen kullanılmalı
Son dakika haberi: Türkiye'de ve dünyada corona aşısı ve tedavisi için çalışmalar hız kesmeden devam ediyor. Aşı ve tedavi geliştirmek için çalışmalar yapan Prof. Dr. Ercüment Ovalı'dan heyecanlandıran açıklama geldi.

http://www.haber7.com/guncel/haber/2...n-kullanilmali

hadi bakalım inşallah neden olmasın

[mrtk]

Evin karşısında İstanbul'un en büyük projelerinden biri başlamıştı geçen sene, yaklaşık 1.5 senedir de durmuştu inşaat. Şantiyeye adam bile gelmiyordu. Yüksek katta oturduğumdan tüm olaya hakimim. Şey olayı başladığından beri bu ekonomiye rağmen adamlar gece gündüz çalışmaya başladılar, Mart ortasından itibaren. Önceden mi planlandı yoksa başka bir şey mi var bilmiyorum. Yorum yapabilecek olan var mı ? Ben bu inşaat batar diye düşünüyordum.

[666]

Devlet tesvik mi sagladi diyorsun mrtk?

[mrtk]

Devlet tesvik mi sagladi diyorsun mrtk?

Bilmiyorum işte soruyorum, Dolar 7 lira olmuş, resesyon geliyor adamlar inşaata başladı.

[666]

Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment

By Adam Feuerstein and Matthew Herper

April 16, 2020


Chicago hospital treating severe Covid-19 patients with Gilead Sciences’ antiviral medicine remdesivir in a closely watched clinical trial is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week, STAT has learned.

Remdesivir was one of the first medicines identified as having the potential to impact SARS-CoV-2, the novel coronavirus that causes Covid-19, in lab tests. The entire world has been waiting for results from Gilead’s clinical trials, and positive results would likely lead to fast approvals by the Food and Drug Administration and other regulatory agencies. If safe and effective, it could become the first approved treatment against the disease.

The University of Chicago Medicine recruited 125 people with Covid-19 into Gilead’s two Phase 3 clinical trials. Of those people, 113 had severe disease. All the patients have been treated with daily infusions of remdesivir.

[mrtk]

Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment

By Adam Feuerstein and Matthew Herper

April 16, 2020


Chicago hospital treating severe Covid-19 patients with Gilead Sciences’ antiviral medicine remdesivir in a closely watched clinical trial is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week, STAT has learned.

Remdesivir was one of the first medicines identified as having the potential to impact SARS-CoV-2, the novel coronavirus that causes Covid-19, in lab tests. The entire world has been waiting for results from Gilead’s clinical trials, and positive results would likely lead to fast approvals by the Food and Drug Administration and other regulatory agencies. If safe and effective, it could become the first approved treatment against the disease.

The University of Chicago Medicine recruited 125 people with Covid-19 into Gilead’s two Phase 3 clinical trials. Of those people, 113 had severe disease. All the patients have been treated with daily infusions of remdesivir.

İlaç üstüne ilaç bulunuyor, bizimkiler de buldu birşeyler hadi baklaım inşallah...